Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-25-000745
Filing Date
2025-02-04
Accepted
2025-02-04 10:29:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4327
  Complete submission text file 0001085146-25-000745.txt   6227
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Subject) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92957 | Film No.: 25585959
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 10 STERLING BLVD SUITE 402 ENGLEWOOD NJ 07631
Business Address 10 STERLING BLVD SUITE 402 ENGLEWOOD NJ 07631 201-731-7112
PATHSTONE FAMILY OFFICE, LLC (Filed by) CIK: 0001511137 (see all company filings)

EIN.: 271957427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G